Quick Answer
Spyre Therapeutics, Inc. reported Common Stock Shares Outstanding of 78.19 million shares for the year ending 2025.
- Spyre Therapeutics, Inc. showed an increase of +29.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Spyre Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Spyre Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 10,224.3%.
- Historical annual values: Fiscal year 2025: 78.19 million shares | Fiscal year 2024: 60.26 million shares | Fiscal year 2023: 36.06 million shares | Fiscal year 2022: 2.61 million shares | Fiscal year 2021: 49.36 million shares | Fiscal year 2020: 47.96 million shares | Fiscal year 2019: 29.08 million shares | Fiscal year 2018: 24.14 million shares | Fiscal year 2017: 16.67 million shares | Fiscal year 2016: 13.43 million shares | Fiscal year 2015: 757,336 shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: